Distribution and Variation of Serotypes and Pneumococcal Surface Protein A Clades of


Journal

Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359

Informations de publication

Date de publication:
2021
Historique:
received: 21 10 2020
accepted: 26 02 2021
entrez: 19 4 2021
pubmed: 20 4 2021
medline: 3 7 2021
Statut: epublish

Résumé

Pneumococcal surface protein A (PspA) is a surface protein of

Identifiants

pubmed: 33869075
doi: 10.3389/fcimb.2021.617573
pmc: PMC8044978
doi:

Substances chimiques

Bacterial Proteins 0
Pneumococcal Vaccines 0
Vaccines, Conjugate 0
pneumococcal surface protein A 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

617573

Informations de copyright

Copyright © 2021 Chang, Kinjo, Morita, Tamura, Watanabe, Tanabe, Kuronuma, Fujita, Oshima, Maruyama, Abe, Kasahara, Nishi, Kubota, Ohnishi, Suga and Oishi.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Ann Am Thorac Soc. 2016 Jun;13(6):933-44
pubmed: 27088424
Vaccine. 2016 Mar 18;34(13):1540-1550
pubmed: 26899372
Microbiology (Reading). 1998 Nov;144 ( Pt 11):3049-3060
pubmed: 9846740
Vaccine. 2020 Feb 11;38(7):1818-1824
pubmed: 31882246
BMC Microbiol. 2009 May 06;9:80
pubmed: 19419534
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
BMC Infect Dis. 2017 Jan 3;17(1):2
pubmed: 28049447
J Clin Microbiol. 2003 Sep;41(9):4194-216
pubmed: 12958247
Vaccine. 2015 Nov 9;33(45):6054-60
pubmed: 26235372
J Exp Med. 1984 Aug 1;160(2):386-97
pubmed: 6381634
Infect Chemother. 2016 Dec;48(4):257-266
pubmed: 28032483
Vaccine. 2016 Jan 20;34(4):474-478
pubmed: 26706276
J Med Microbiol. 2018 Aug;67(8):1130-1138
pubmed: 29927374
Infect Immun. 2000 Oct;68(10):5889-900
pubmed: 10992499
mBio. 2020 May 19;11(3):
pubmed: 32430472
J Clin Microbiol. 2006 Aug;44(8):2838-43
pubmed: 16891500
Eur J Clin Microbiol Infect Dis. 2012 Mar;31(3):217-23
pubmed: 21643868
Vaccine. 2014 Sep 29;32(43):5607-13
pubmed: 25132335
Emerg Infect Dis. 2020 Oct;26(10):2378-2386
pubmed: 32946721
Microb Pathog. 1994 Nov;17(5):323-37
pubmed: 7723659
Proc Natl Acad Sci U S A. 2017 Jan 17;114(3):E357-E366
pubmed: 28053228
Hum Vaccin Immunother. 2016;12(2):358-74
pubmed: 26905681
Microbiol Spectr. 2019 Nov;7(6):
pubmed: 31858954
PLoS One. 2019 Feb 21;14(2):e0212418
pubmed: 30789928
Vaccine. 2018 Jul 5;36(29):4304-4310
pubmed: 29871816
PLoS One. 2017 Nov 13;12(11):e0183968
pubmed: 29131872

Auteurs

Bin Chang (B)

Department of Bacteriology I, National Institute of Infectious Diseases, Tokyo, Japan.

Yuki Kinjo (Y)

Department of Bacteriology, The Jikei University School of Medicine, Tokyo, Japan.
Jikei Center for Biofilm Science and Technology, The Jikei University School of Medicine, Tokyo, Japan.
Department of Intelligent Network for Infection Control, Tohoku University Graduate School of Medicine, Sendai, Japan.

Masatomo Morita (M)

Department of Bacteriology I, National Institute of Infectious Diseases, Tokyo, Japan.

Kosuke Tamura (K)

Toyama Institute of Health, Toyama, Japan.

Hiroshi Watanabe (H)

Department of Infection Control and Prevention, Kurume University School of Medicine, Fukuoka, Japan.

Yoshinari Tanabe (Y)

Department of Respiratory Medicine, Niigata Prefectural Shibata Hospital, Niigata, Japan.

Koji Kuronuma (K)

Department of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, Hokkaido, Japan.

Jiro Fujita (J)

Department of Infectious, Respiratory, and Digestive Medicine, Faculty of Medicine, University of the Ryukyus, Okinawa, Japan.

Kengo Oshima (K)

Department of Infection Control and Laboratory Diagnostics, Internal Medicine, Tohoku University Graduate School of Medicine, Miyagi, Japan.

Takaya Maruyama (T)

Department of Medicine, National Hospital Organization, Mie Hospital, Mie, Japan.

Shuichi Abe (S)

Yamagata Prefectural Central Hospital, Yamagata, Japan.

Kei Kasahara (K)

Center for Infectious Diseases, Nara Medical University, Nara, Japan.

Junichiro Nishi (J)

Department of Microbiology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.

Tetsuya Kubota (T)

Department of Respiratory Medicine and Allergology, Kochi Medical School, Kochi University, Kochi, Japan.

Makoto Ohnishi (M)

Department of Bacteriology I, National Institute of Infectious Diseases, Tokyo, Japan.

Shigeru Suga (S)

National Hospital Organization Mie National Hospital, Mie, Japan.

Kazunori Oishi (K)

Toyama Institute of Health, Toyama, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH